Vasopressin plus corticosteroids: The shock duo!

Critical Care Medicine

Volumn 37, Issue 3, 2009, Pages 1126-1127

  Annane, Djillali ^a  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

Clinical trials; Hormones; Hydrocortisone; Septic shock

Indexed keywords

HYDROCORTISONE; NORADRENALIN; VASOPRESSIN; CORTICOSTEROID; VASOPRESSIN DERIVATIVE;

ADRENAL FUNCTION; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; DRUG POTENTIATION; EDITORIAL; HEMODYNAMICS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NONHUMAN; ORGAN; PHYSICIAN; POPULATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEPTIC SHOCK; SURVIVAL; DRUG COMBINATION; NOTE;

ADRENAL CORTEX HORMONES; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; HYDROCORTISONE; SHOCK, SEPTIC; VASOPRESSINS;

EID: 62849107838     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31819879c1     Document Type: Editorial

References (15)

1. Russell JA, Walley KR, Gordon A, et al: Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med 2009; 37:811-818
2. Russel JA, Walley KR, Singer J, et al: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358:877-887
3. Sharshar T, Annane D: Endocrine effects of vasopressin in critically ill patients. Best Pract Res Clin Anaesthesiol 2008; 22: 265-273
4. Lauand F, Ruginsk SG, Rodrigues HL, et al: Glucocorticoid modulation of atrial natriuretic peptide, oxytocin, vasopressin and Fos expression in response to osmotic, angiotensinergic and cholinergic stimulation. Neuroscience 2007; 147:245-257
5. Ruginsk SG, Oliveira FR, Margatho LO, et al: Glucocorticoid modulation of neuronal activity and hormone secretion induced by blood volume expansion. Exp Neurol 2007; 206:192-200
6. Bähr V, Franzen N, Oelkers W, et al: Effect of exogenous gluococorticoid on osmotically stimulated antidiuretic hormone secretion and on water reabsorption. Eur J Endocrinol 2006; 155:845-848
7. Dü nser MW, Mayr AJ, Ulmer H, et al: Arginine vasopressin in advanced vasodilatory shock: A prospective, randomized, controlled study. Circulation 2003; 107:2313-2319
8. Lauzier F, Levy B, Lamarre P, et al: Vasopressin or norepinephrine in early hyperdynamic septic shock: A randomized clinical trial. Intensive Care Med 2006; 32:1782-1789
9. Brackett DJ, Schaefer CF, Tompkins P, et al: Evaluation of cardiac output, total peripheral vascular resistance, and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia. Circ Shock 1985; 17:273-284
10. Sharshar T, Carlier R, Blanchard A, et al: Depletion of neurohypophyseal content of vasopressin in septic shock. Crit Care Med 2002; 30:497-501
11. Carnio EC, Stabile AM, Batalhao ME, et al: Vasopressin release during endotoxaemic shock in mice lacking inducible nitric oxide synthase. Pflugers Arch 2005; 450:390-394
12. Batalhao ME, Moreto V, Stabile AM, et al: Role of dexamethasone on vasopressin release during endotoxemic shock. Regul Pept 2008; 147:67-71
13. Ertmer C, Bone HG, Morelli A, et al: Meth-ylprednisolone reverses vasopressin hypore-sponsiveness in ovine endotoxemia. Shock 2007; 27:281-288
14. Wang R, Lagakos LW, Ware JH, et al: Statistics in medicine: Reporting of subgroup analyses in clinical trial. N Engl J Med 2007; 357:2189-2194
15. Sprung CL, Annane D, Keh D, et al: Hydro-cortisone therapy for patients with septic shock. N Engl J Med 2008; 358:111-124